These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20971816)

  • 1. CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features.
    Schmidt-Hieber M; Pérez-Andrés M; Paiva B; Flores-Montero J; Perez JJ; Gutierrez NC; Vidriales MB; Matarraz S; San Miguel JF; Orfao A
    Haematologica; 2011 Feb; 96(2):328-32. PubMed ID: 20971816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-kit receptor (CD117) expression on plasma cells in monoclonal gammopathies.
    Kraj M; Pogłód R; Kopeć-Szlezak J; Sokołowska U; Woźniak J; Kruk B
    Leuk Lymphoma; 2004 Nov; 45(11):2281-9. PubMed ID: 15512818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma.
    Paiva B; Pérez-Andrés M; Vídriales MB; Almeida J; de las Heras N; Mateos MV; López-Corral L; Gutiérrez NC; Blanco J; Oriol A; Hernández MT; de Arriba F; de Coca AG; Terol MJ; de la Rubia J; González Y; Martín A; Sureda A; Schmidt-Hieber M; Schmitz A; Johnsen HE; Lahuerta JJ; Bladé J; San-Miguel JF; Orfao A; ;
    Leukemia; 2011 Apr; 25(4):697-706. PubMed ID: 21252988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma.
    Billadeau D; Van Ness B; Kimlinger T; Kyle RA; Therneau TM; Greipp PR; Witzig TE
    Blood; 1996 Jul; 88(1):289-96. PubMed ID: 8704185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Lacy MQ; Donovan KA; Heimbach JK; Ahmann GJ; Lust JA
    Blood; 1999 Jan; 93(1):300-5. PubMed ID: 9864174
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Bolzoni M; Ronchetti D; Storti P; Donofrio G; Marchica V; Costa F; Agnelli L; Toscani D; Vescovini R; Todoerti K; Bonomini S; Sammarelli G; Vecchi A; Guasco D; Accardi F; Palma BD; Gamberi B; Ferrari C; Neri A; Aversa F; Giuliani N
    Haematologica; 2017 Apr; 102(4):773-784. PubMed ID: 28057743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
    Chiecchio L; Dagrada GP; Ibrahim AH; Dachs Cabanas E; Protheroe RK; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
    Haematologica; 2009 Dec; 94(12):1708-13. PubMed ID: 19996118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hMLH1 and MGMT inactivation as a mechanism of tumorigenesis in monoclonal gammopathies.
    Martin P; Santón A; García-Cosio M; Bellas C
    Mod Pathol; 2006 Jul; 19(7):914-21. PubMed ID: 16607377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis.
    Escribano L; Ocqueteau M; Almeida J; Orfao A; San Miguel JF
    Leuk Lymphoma; 1998 Aug; 30(5-6):459-66. PubMed ID: 9711908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the CD117 antigen (c-Kit) on normal and myelomatous plasma cells.
    Ocqueteau M; Orfao A; García-Sanz R; Almeida J; Gonzalez M; San Miguel JF
    Br J Haematol; 1996 Dec; 95(3):489-93. PubMed ID: 8943889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis.
    Bataille R; Pellat-Deceunynck C; Robillard N; Avet-Loiseau H; Harousseau JL; Moreau P
    Leuk Res; 2008 Mar; 32(3):379-82. PubMed ID: 17767956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
    Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ;
    Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of B-cell subpopulations in monoclonal gammopathies.
    Všianská P; Říhová L; Varmužová T; Suská R; Kryukov F; Mikulášová A; Kupská R; Penka M; Pour L; Adam Z; Hájek R
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):e61-71. PubMed ID: 25578543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Thiago LS; Perez-Andres M; Balanzategui A; Sarasquete ME; Paiva B; Jara-Acevedo M; Barcena P; Sanchez ML; Almeida J; González M; San Miguel JF; Garcia-Sanz R; Orfao A
    Haematologica; 2014 Jan; 99(1):155-62. PubMed ID: 23872308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct and shared three-dimensional chromosome organization patterns in lymphocytes, monoclonal gammopathy of undetermined significance and multiple myeloma.
    Sathitruangsak C; Righolt CH; Klewes L; Tung Chang D; Kotb R; Mai S
    Int J Cancer; 2017 Jan; 140(2):400-410. PubMed ID: 27711972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.
    Schmidt-Hieber M; Gutiérrez ML; Pérez-Andrés M; Paiva B; Rasillo A; Tabernero MD; Sayagués JM; Lopez A; Bárcena P; Sanchez ML; Gutiérrez NC; San Miguel JF; Orfao A
    Haematologica; 2013 Feb; 98(2):279-87. PubMed ID: 22929983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoglobulin heavy chain gene rearrangements in the monoclonal gammopathies].
    Bosaleh A; Denninghoff V; Garcia A; Rescia C; Avagnina A; Elsner B
    Medicina (B Aires); 2005; 65(3):219-25. PubMed ID: 16042132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.